Next Article in Journal
Accentuated Peripheral Blood NK Cytotoxicity Forms an Unfavorable Background for Embryo Implantation and Gestation
Next Article in Special Issue
Alveolar Soft Part Sarcoma of the Uterus: Clinicopathological and Molecular Characteristics
Previous Article in Journal
A Rare Case of Amyloidoma of the Chest Wall Presented with Fever of Unknown Origin
Previous Article in Special Issue
Dissecting Gonadoblastoma of the Ovary Coexistent with an Atypical Endometriotic Cyst: Incidental Detection in Cystectomy Specimen of a Woman with 46,XX Karyotype
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

COVID-19 Pandemic Effects on Cervical Cancer Diagnosis and Management: A Population-Based Study in Romania

1
Department of Obstetrics and Gynecology, “Victor Babes” University of Medicine and Pharmacy, 300041 Timisoara, Romania
2
Department of General Surgery, “Victor Babes” University of Medicine and Pharmacy, 300041 Timisoara, Romania
3
Methodological and Infectious Diseases Research Center, Department of Infectious Diseases, “Victor Babes” University of Medicine and Pharmacy, 300041 Timisoara, Romania
4
Department of Orthopedics, “Victor Babes” University of Medicine and Pharmacy, 300041 Timisoara, Romania
5
Doctoral School, “Victor Babes” University of Medicine and Pharmacy, 300041 Timisoara, Romania
*
Author to whom correspondence should be addressed.
Diagnostics 2022, 12(4), 907; https://doi.org/10.3390/diagnostics12040907
Submission received: 13 February 2022 / Revised: 3 April 2022 / Accepted: 4 April 2022 / Published: 6 April 2022
(This article belongs to the Special Issue Diagnosis and Management of Gynecological Cancers)

Abstract

The Pap test plays a significant role worldwide in the early diagnosis of and high curability rates for cervical cancer. However, the coronavirus disease 2019 (COVID-19) pandemic necessitated the use of multiple drastic measures to stop the spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus, limiting women’s access to essential invasive and non-invasive investigations for cervical cancer diagnosis. Therefore, we aimed to determine the impact the COVID-19 pandemic had on cancer diagnosis and management in western Romania. A retrospective study design allowed us to compare the last 24 months of the pre-pandemic period with the first 24 months of the COVID-19 pandemic to determine the change in volume of cervical screening tests, the number of newly diagnosed cases and their severity, and the access to cancer care. A drastic 75.5% decrease in the volume of tests was observed in April 2020 during the first lockdown, after which the volume of cases decreased by up to 36.1% in December 2021. The total volume loss of tests during the first 24 months of the pandemic was 49.9%. The percentage of late-stage cervical cancers (III–IV) rose by 17%, while the number of newly diagnosed cancers in our outpatient clinic was significantly lower than the baseline, with a 45% drop. The access to cancer care was negatively influenced, with 9.2% more patients waiting longer to receive test results over four weeks, while taking longer to seek cancer care after diagnosis (6.4 months vs. 4.1 months pre-pandemic) and missing significantly more appointments. The COVID-19 pandemic had a significantly negative impact on cervical cancer diagnosis and management during the first 24 months compared with the same period before the pandemic. Although the numbers are now recovering, there is still a big gap, meaning that many cervical cancer cases were potentially missed. We recommend further interventions to reduce the gap between the pre-pandemic and pandemic period.
Keywords: SARS-CoV-2; COVID-19; cervical cancer; cancer diagnosis SARS-CoV-2; COVID-19; cervical cancer; cancer diagnosis

Share and Cite

MDPI and ACS Style

Popescu, A.; Craina, M.; Pantea, S.; Pirvu, C.; Chiriac, V.D.; Marincu, I.; Bratosin, F.; Bogdan, I.; Hosin, S.; Citu, C.; et al. COVID-19 Pandemic Effects on Cervical Cancer Diagnosis and Management: A Population-Based Study in Romania. Diagnostics 2022, 12, 907. https://doi.org/10.3390/diagnostics12040907

AMA Style

Popescu A, Craina M, Pantea S, Pirvu C, Chiriac VD, Marincu I, Bratosin F, Bogdan I, Hosin S, Citu C, et al. COVID-19 Pandemic Effects on Cervical Cancer Diagnosis and Management: A Population-Based Study in Romania. Diagnostics. 2022; 12(4):907. https://doi.org/10.3390/diagnostics12040907

Chicago/Turabian Style

Popescu, Alin, Marius Craina, Stelian Pantea, Catalin Pirvu, Veronica Daniela Chiriac, Iosif Marincu, Felix Bratosin, Iulia Bogdan, Samer Hosin, Cosmin Citu, and et al. 2022. "COVID-19 Pandemic Effects on Cervical Cancer Diagnosis and Management: A Population-Based Study in Romania" Diagnostics 12, no. 4: 907. https://doi.org/10.3390/diagnostics12040907

APA Style

Popescu, A., Craina, M., Pantea, S., Pirvu, C., Chiriac, V. D., Marincu, I., Bratosin, F., Bogdan, I., Hosin, S., Citu, C., Bernad, E., Neamtu, R., Dumitru, C., Mocanu, A. G., Avram, C., & Gluhovschi, A. (2022). COVID-19 Pandemic Effects on Cervical Cancer Diagnosis and Management: A Population-Based Study in Romania. Diagnostics, 12(4), 907. https://doi.org/10.3390/diagnostics12040907

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop